Correction to: CART cells are prone to Fas- and DR5-mediated cell death

J Immunother Cancer. 2018 Sep 25;6(1):92. doi: 10.1186/s40425-018-0410-2.

Benjamin O Tschumi¹, Nina Dumauthioz¹, Bastien Marti¹, Lianjun Zhang¹, Evripidis Lanitis^{2

3}, Melita Irving^{2

3}, Pascal Schneider⁴, Jean-Pierre Mach⁴, George Coukos^{2

3}, Pedro Romero¹, Alena Donda⁵

¹ Department of Fundamental Oncology, Translational Tumor Immunology Group, Lausanne, Switzerland.
² Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland.
³ Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.
⁴ Department of Biochemistry, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
⁵ Department of Fundamental Oncology, Translational Tumor Immunology Group, Lausanne, Switzerland. Alena.donda@unil.ch.

Abstract

After publication of this article [1], it was noticed that 3 authors were missed from the author list.